Acadia Healthcare Highlights $200M EBITDA Upside as New Beds Ramp Amid Medicaid, Staffing Headwinds

1 hour ago 1

MarketBeat

Tue, March 10, 2026 astatine 11:48 AM CDT 6 min read

Acadia Healthcare logo

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

Acadia Healthcare (NASDAQ:ACHC) CFO Todd Young discussed the company’s operational priorities, argumentation headwinds, and currency travel outlook during a speech astatine the Barclays Global Healthcare Conference. Young, who said helium has been successful the CFO relation for “just implicit 4 months,” emphasized execution and occupancy arsenic cardinal themes for 2026 arsenic the institution works to ramp precocious opened capableness and respond to payer and regulatory changes.

Young said the instrumentality of CEO Debbie Osteen has been “invigorating to the operators,” pointing to her decades of behavioral wellness experience, including much than 30 years astatine Universal Health Services moving behavioral health, 3 years arsenic Acadia’s CEO, and her instrumentality to the role. Young said Acadia has added 3,000 caller beds crossed the state by the extremity of this twelvemonth and framed the cardinal accidental arsenic filling those beds portion moving facilities good from an operating perspective.

→ 3 European Stocks for Riding Out Market Volatility

Young reiterated management’s presumption that Acadia has astir $200 cardinal of “embedded EBITDA” accidental wrong the 3,000 beds added successful the 2023–2025 period. While noting helium was not with the institution during overmuch of the ramp, Young said the underperformance has not been driven by a azygous origin crossed each facilities and described a “confluence of events.” He cited licensure delays arsenic 1 contented that slowed the quality to admit Medicaid patients, which helium said are a large operator successful the acute setting, including involuntarily committed patients.

Young said the institution is focused connected strengthening pre-opening activities and accelerating the timing of diligent additions aft openings. He besides said occupancy astatine newer facilities is “behind,” and that Acadia has provided cohort curves comparing show to past and expectations. He did not supply facility-by-facility occupancy details but said expanding inpatient occupancy is simply a superior absorption due to the fact that treating much patients drives gross and profitability.

→ Credo Technologies Hits Bottom: Now Is the Time to Buy

Discussing measurement betterment and the company’s 2026 assumptions, Young said the astir 4% maturation referenced for 2026 (before considering the New York Medicaid impact) is driven by execution alternatively than a deficiency of demand. He described 2 maturation levers:

Expansion beds astatine existing facilities: Young said erstwhile a installation reaches astir 75%–80% occupancy, it becomes harder to lucifer diligent needs to disposable furniture types, and adding beds tin amended throughput. He said expansions tin leverage existing infrastructure and enactment and mostly transportation amended publication margins than gathering caller facilities.
Ramping newer cohorts: Young said the furniture cohorts opened from 2023 to 2025 should amended and “lose little wealth successful 2026 than they did successful 2025,” contributing to measurement and profitability.

Read Entire Article